CB4Cancer

CB4Cancer enables early detection of blood cancer, which is otherwise difficult to diagnose in early stage, saving lives while reducing the medical cost

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New Haven, CT, USA
  • Currency USD
  • Founded December 2023
  • Employees 5
  • Incorporation Type LLC

Company Summary

CB4Cancer was founded by Precipio, an expert in blood biopsies diagnostics, and Eshed Doni, a serial health tech innovator with a track record of successful ventures.

CB4Cancer developed the only cancer-prediction test-less solution that relies solely on an existing standard low cost test to predict the development of cancer. It provides medical insurance companies a very affordable solution that yields a 14X Return On Investment.

Team

Previous Investors

  • Precipio
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free